Blackstone to Buy Takeda Pharma’s Japanese Consumer Healthcare Business for $2.29 billion; Target Price $60

U.S. investment fund Blackstone Group said on Monday that it will acquire Takeda Pharmaceutical’s Japanese consumer healthcare business for $2.29 billion, marking Blackstone’s second private equity …
( read original story …)

---